Exogenous melatonin can regulate circadian rhythms in prostate cancer cells by upregulating the expression of core clock genes such as PER2 and CLOCK, while downregulating the levels of BMAL1 [244]. The gene discussed is CLOCK; the disease is prostate cancer.